Jazz Pharmaceuticals(JAZZ) - 2025 Q2 - Earnings Call Presentation

August 5, 2025 2025 Second Quarter Financial Results Innovating to Transform the Lives of Patients and Their Families EPIDIOLEX® patient diagnosed with Dravet syndrome Caution Concerning Forward-Looking Statements This presentation contains forward-looking statements and financial targets, including, but not limited to, statements related to: the Company's growth prospects and future financial and operating results, including the Company's 2025 financial guidance and the Company's expectations related there ...